Joshua McHale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joshua McHale has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Carlo Vascotto
IMol Polish Academy of Sciences
2 shared publications - Veronica Bazzani
IMol Polish Academy of Sciences
2 shared publications - Abdechakour Elkihel
Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), UMR 7325, Equipe Labellisée Ligue Contre le Cancer, 13288 Marseille, France
1 shared publication Alexandros Kostakis
Strike Pharma AB, Lund, Sweden
1 shared publication- Annemieke Madder
Organic and Biomimetic Chemistry Research Group, Department of Organic and Macromolecular Chemistry, Ghent University, Ghent, Belgium
1 shared publication Carlo Vascotto
IMol Polish Academy of Sciences, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 10 October 2026
- Published by Springer Nature in Communications Chemistry
Modular multifunctional 5HP2O linkers for the versatile assembly of protein-oligonucleotide conjugates
As complex biotherapeutics continue to evolve, the demand for single-site, multi-functionalized protein conjugates intensifies. Current methods often suffer from maleimide-related hydrolytic instability or require multi-step invasive protein modifications. Here, we establish 5-hydroxy-1,5-dihydro-2H-pyrrol-2-ones (5HP2O) as modular, hydrolytically stable hubs for assembling multi-functional protein-oligonucleotide conjugates (POCs). Synthesized via one-pot photooxidation of 2-substituted furans, these linkers incorporate tunable spacers, 5HP2O Michael acceptor, a NHS active ester and secondary cargoes. We demonstrate that 5HP2O-functionalized amino-oligonucleotides (AON) maintain complete hydrolytic resistance across a broad pH range, streamlining intermediate storage. Subsequent bioconjugation yields constructs with superior retro-Michael stability compared to aliphatic maleimide analogues. Expanding this platform, we generated diverse heterobifunctional, trifunctional (click-reactive and fluorescent), and tetrafunctional (enzymatically cleavable) linkers. We validated these tools through in vitro conjugate tracking and the assembly of a dual-antisense oligonucleotide conjugate.
- 10 October 2026
- Published by Springer Nature in Communications Chemistry
Open AccessModular multifunctional 5HP2O linkers for the versatile assembly of protein-oligonucleotide conjugates
As complex biotherapeutics continue to evolve, the demand for single-site, multi-functionalized protein conjugates intensifies. Current methods often suffer from maleimide-related hydrolytic instability or require multi-step invasive protein modifications. Here, we establish 5-hydroxy-1,5-dihydro-2H-pyrrol-2-ones (5HP2O) as modular, hydrolytically stable hubs for assembling multi-functional protein-oligonucleotide conjugates (POCs). Synthesized via one-pot photooxidation of 2-substituted furans, these linkers incorporate tunable spacers, 5HP2O Michael acceptor, a NHS active ester and secondary cargoes. We demonstrate that 5HP2O-functionalized amino-oligonucleotides (AON) maintain complete hydrolytic resistance across a broad pH range, streamlining intermediate storage. Subsequent bioconjugation yields constructs with superior retro-Michael stability compared to aliphatic maleimide analogues. Expanding this platform, we generated diverse heterobifunctional, trifunctional (click-reactive and fluorescent), and tetrafunctional (enzymatically cleavable) linkers. We validated these tools through in vitro conjugate tracking and the assembly of a dual-antisense oligonucleotide conjugate.
- Open Access
- 26 March 2026
- Published by Taylor & Francis in BioTechniques
- Vol. 78 (1-12) , 1-11
Quantitative analysis of oligonucleotide delivery into isolated mitochondria: a proof-of-concept method
Mitochondria, with their own DNA, Represent a potential target for nucleic acid-based precision therapies. However, effective delivery of therapeutic oligonucleotides remains challenging due to the dual mitochondrial membranes and the localization of mitochondrial DNA within nucleoid complexes in the matrix. To understand the delivery process and assess the delivery efficiency of potential vectors, such as dendrimers, it is essential to effectively quantify the oligonucleotides that are successfully delivered to and remain within mitochondria. Currently, there are only limited yet inconvenient methods available for this purpose. Here, we describe a method for quantifying the delivery of fluorescent oligonucleotide cargos in isolated mitochondria using a microfiltration apparatus for reliable fluorescent analysis. By working within a range of dilutions, we are able to safeguard the concentration limits. The quantification protocol also enables the visualization of specific localization within mitochondria, allowing for the determination of whether delivery can occur across both membranes. This is particularly useful, as it offers a key insight into improving vectors as they must deliver the cargoes within the mitochondrial matrix. We validate this method in this proof-of-concept study, providing biological data to assess the difference between two amphiphilic dendrimer vectors for oligonucleotide delivery in mitochondria.
- 26 March 2026
- Published by Taylor & Francis in BioTechniques
- Vol. 78 (1-12) , 1-11
Open AccessQuantitative analysis of oligonucleotide delivery into isolated mitochondria: a proof-of-concept method
Mitochondria, with their own DNA, Represent a potential target for nucleic acid-based precision therapies. However, effective delivery of therapeutic oligonucleotides remains challenging due to the dual mitochondrial membranes and the localization of mitochondrial DNA within nucleoid complexes in the matrix. To understand the delivery process and assess the delivery efficiency of potential vectors, such as dendrimers, it is essential to effectively quantify the oligonucleotides that are successfully delivered to and remain within mitochondria. Currently, there are only limited yet inconvenient methods available for this purpose. Here, we describe a method for quantifying the delivery of fluorescent oligonucleotide cargos in isolated mitochondria using a microfiltration apparatus for reliable fluorescent analysis. By working within a range of dilutions, we are able to safeguard the concentration limits. The quantification protocol also enables the visualization of specific localization within mitochondria, allowing for the determination of whether delivery can occur across both membranes. This is particularly useful, as it offers a key insight into improving vectors as they must deliver the cargoes within the mitochondrial matrix. We validate this method in this proof-of-concept study, providing biological data to assess the difference between two amphiphilic dendrimer vectors for oligonucleotide delivery in mitochondria.
- Open Access
- 27 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11391
Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing
Mitochondria are the only organelles, along with the nucleus, that have their own DNA. Mitochondrial DNA (mtDNA) is a double-stranded circular molecule of ~16.5 kbp that can exist in multiple copies within the organelle. Both strands are translated and encode for 22 tRNAs, 2 rRNAs, and 13 proteins. mtDNA molecules are anchored to the inner mitochondrial membrane and, in association with proteins, form a structure called nucleoid, which exerts a structural and protective function. Indeed, mitochondria have evolved mechanisms necessary to protect their DNA from chemical and physical lesions such as DNA repair pathways similar to those present in the nucleus. However, there are mitochondria-specific mechanisms such as rapid mtDNA turnover, fission, fusion, and mitophagy. Nevertheless, mtDNA mutations may be abundant in somatic tissue due mainly to the proximity of the mtDNA to the oxidative phosphorylation (OXPHOS) system and, consequently, to the reactive oxygen species (ROS) formed during ATP production. In this review, we summarise the most common types of mtDNA lesions and mitochondria repair mechanisms. The second part of the review focuses on the physiological role of mtDNA damage in ageing and the effect of mtDNA mutations in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Considering the central role of mitochondria in maintaining cellular homeostasis, the analysis of mitochondrial function is a central point for developing personalised medicine.
- 27 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11391
Open AccessMitochondrial DNA Repair in Neurodegenerative Diseases and Ageing
Mitochondria are the only organelles, along with the nucleus, that have their own DNA. Mitochondrial DNA (mtDNA) is a double-stranded circular molecule of ~16.5 kbp that can exist in multiple copies within the organelle. Both strands are translated and encode for 22 tRNAs, 2 rRNAs, and 13 proteins. mtDNA molecules are anchored to the inner mitochondrial membrane and, in association with proteins, form a structure called nucleoid, which exerts a structural and protective function. Indeed, mitochondria have evolved mechanisms necessary to protect their DNA from chemical and physical lesions such as DNA repair pathways similar to those present in the nucleus. However, there are mitochondria-specific mechanisms such as rapid mtDNA turnover, fission, fusion, and mitophagy. Nevertheless, mtDNA mutations may be abundant in somatic tissue due mainly to the proximity of the mtDNA to the oxidative phosphorylation (OXPHOS) system and, consequently, to the reactive oxygen species (ROS) formed during ATP production. In this review, we summarise the most common types of mtDNA lesions and mitochondria repair mechanisms. The second part of the review focuses on the physiological role of mtDNA damage in ageing and the effect of mtDNA mutations in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Considering the central role of mitochondria in maintaining cellular homeostasis, the analysis of mitochondrial function is a central point for developing personalised medicine.